Literature DB >> 32477996

Nivolumab (PD-1 Inhibitor) Induced Exacerbation of Psoriasis.

Anju George1, Renu George1.   

Abstract

Entities:  

Year:  2020        PMID： 32477996      PMCID： PMC7247661          DOI： 10.4103/idoj.IDOJ_47_19

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN： 2229-5178


× No keyword cloud information.
  4 in total

1.  Exacerbation of Psoriasis During Nivolumab Therapy for Metastatic Melanoma.

Authors:  Natsuko Matsumura; Mikio Ohtsuka; Nobuyuki Kikuchi; Toshiyuki Yamamoto
Journal:  Acta Derm Venereol       Date:  2016-02       Impact factor: 4.437

2.  Occurrence of Psoriasiform Eruption During Nivolumab Therapy for Primary Oral Mucosal Melanoma.

Authors:  Mikio Ohtsuka; Takako Miura; Tatsuhiko Mori; Masato Ishikawa; Toshiyuki Yamamoto
Journal:  JAMA Dermatol       Date:  2015-07       Impact factor: 10.282

3.  Anti-PD1-induced psoriasis: a study of 21 patients.

Authors:  J Bonigen; C Raynaud-Donzel; J Hureaux; N Kramkimel; A Blom; G Jeudy; A-L Breton; T Hubiche; C Bedane; D Legoupil; A Pham-Ledard; J Charles; M Pérol; E Gérard; P Combemale; D Bonnet; M-L Sigal; E Mahé
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-11-07       Impact factor: 6.166

4.  Psoriasis or not? Review of 51 clinically confirmed cases reveals an expanded histopathologic spectrum of psoriasis.

Authors:  Thinh Chau; Kory K Parsi; Toru Ogawa; Maija Kiuru; Thomas Konia; Chin-Shang Li; Maxwell A Fung
Journal:  J Cutan Pathol       Date:  2017-09-15       Impact factor: 1.587
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.